Image 3: Stock Price and Trading Volume of Johnson and Johnson Stock Source: Nasdaq
The Johnson and Johnson stock price has been growing constantly in last year. In September 2015 the price was around 110 US dollars and currently the price is over 125 US dollars. In the trading volume chart there are two peaks that are related in time with downs on the stock price of Johnson and Johnson. Hence, there is a correlation between the volume of trading of the stock and the failing of the price.
In the last year the price of the stock increased 13.64%, which is a big number compering with the 7% in this industry. (Global Life Science Outlook, Moving Forward with Cautious Optimism, 2016)
Table 1: Changes in the Johnson and Johnson Stock Price
Period Moving
…show more content…
The higher P/E ratio of JNJ is not favorable compared with the average industry. The dollar for current earnings is higher in Johnson and Johnson case, making the investment less attractive for investors. On the other hand, the P/E ratio of JNJ in a mature industry like pharmaceutical where the investment risks are low is still interesting for investors. The low P/E ratio comparing to JNJ peers could be motivated by the big amount of money that the company invested in research and development and also in the acquisition of other companies like Vogue International. (Valuation Ratios, 2016)
Price to Book Ratio
The price to book ratio of Johnson and Johnson is 4.07, higher than the average of pharmaceutical industry 3.89. The big number reflects how the market interpreted the relationship between JNJ required rate of return and the actual rate of return of the company. The main problem of using the P/B ratio for companies like JNJ is that the book value does not count some intangible assets such brand recognition or patents of the company, affecting the final investment decision.
In the case of JNJ, the number of patents, such as Remicade drugs, that the company owns is quite high. The value of this intellectual rights are not incorporated in the price to book ratio. Moreover, the brand image of JNJ products is superior as the image of the competitors and this value is not reflected in
…show more content…
The Gordon model is more accruable because utilizes dividend information from the previous year and the current price of the stock, therefore the market movements are captured in the stock price. Both dividend growth rates are optimistic.
The main goal of the dividend discount model is to calculate if the present value of the stock company is overpriced or underpriced, hence, the present value of the future dividend is a good calculus. Johnson and Johnson present value of the future dividends is 100.68. On the other hand, the current value of the JNJ stock is 125.23, indicating that the current stock price is overvalued. In addition, the price per share future using the Gordon model is 64.07 indicating once again the current price of the Johnson and Johnson stock is overvalued.
The present value of the stock needs to be carefully interpreted because the interpretation of a stock worth the sum of all its future dividend payments, discounted back to their present value does not count market sentiments, financial decisions or cyclical
...s are doing well and over the many years have gone up. The company has not lawsuits currently pending which is good. The company as a whole seems to be growing even when the market is down.
The stock price is currently 103.31, down from a recent high of 121.50. The P/E ratio is declining at 28 and beta at .67, which is expected to grow closer to 1.0. A recent earnings surprise last December yielded a 15% difference from the lower expectations and the latest earnings reports late last month also surprised investors. Estimates for the 2000 fiscal year are being raised by a large majority of analyst who believe that earnings per share will increase and the stock price will reach close to 150.
Earlier 2002, the stock price of Agnico-Eagle Mines sharply decreased by $1 finally closed at $13.89. This price has reached one of the lowest level, from the company's historical perspective. As a professional equity portfolio manager, who has a large number of AEM stocks on hand. Acker and his team are necessary to find a proper way to estimated the fair value of AEM as well as its equity. Discounted Cash Flow (DCF) has been chosen to do this job. The theory behind DCF valuation approach is that the firm's value can be estimated by using the expected future free cash flow discounted by an appropriate discounted rate (Koller etc 2005). However several assumptions need to be clearly examined within this approach. The following sections are showing the process of DCF step by step.
Theoretically, it is the foundation of simpleness and reasoning for stock valuation as any cash payoff from company is entirely in form of dividends. However, in practice, this model require further hypothesis on company’ dividend payments, future interest rate and growth pattern. Therefore, it is assumed that the DDM model merely applies to evaluate roughly minor proportion of the value of company’ share price. Specifically, the JB HI-FI value obtained from the DDM is 30.65 higher than their actual currently trading share price 24.1; a different of 6.55, and then the stock is undervalued. Consequently, DMM is not applicable for stock price valuation in case of JB HI-FI since it is not an individual approach of stock
Merck's investment valuation Decision tree approach: This approach is suitable for projects that do not have to be funded all at once. The alternatives, probability of payoffs are identified using diagrams which are simple to understand and interpret with brief explanations giving important insights. It identifies managerial flexibility to reevaluate decisions using new information and then either invest additional funds or terminate the project. Results of the decision tree. This analysis shows that the project's NPV is $13.37 million.
Discounted Cash Flow Method takes the forecast free cash flows during forecasted horizon. Then we estimate the cost of capital (weighted average cost of capital) and estimate continuing value (value after forecast horizon). The future value is discounted to the present value. We than add back cash ($13 Million) and non-current assets and deduct total debt. With the information provided several assumptions had to be made to obtain reasonable values (life period of 30-years, Capital expenditures not to exceed $1 million dollars, depreciation to stay constant at $1.15 Million and a discounted rate of 10%). Based on our analysis, the company has a stand-alone value of $51 Million at the end of fiscal year end 1990 with a net present value of cash flows of $33 million that does not include the cash and non-current assets a cash of and non-current assets.
The share price of Woolworths Limited still shows a downward trend until 12th September, and the closing price down to the $22.32 per share, which is the lowset price from past 4 weeks. After that, the price started to smoothly increase to $23.35, but still very low compare with the share prices before the announcement date. Therefore, different investors have different reflect on the earning announcement. Some of them may over react but some may do nothing. There are thousands of participations looking small clues and valuable information in order to predict the share price. However, due to the lager number of participations, the share price is constantly changing. In another words, it is too late to make use of all the information that has been obtained to determine the share price and to act (Ball 1995, p.
In mid September 2005, Ashley Swenson, the chief financial officer of this large CAD/CAM equipment manufacturer must decide whether to pay out dividends to the firm¡¦s shareholders or repurchase stock. If Swenson chooses to pay out dividends, she must also decide on the magnitude of the payout. A subsidiary question is whether the firm should embark on a campaign of corporate-image advertising and change its corporate name to reflect its new outlook. The case serves a review of the many practical aspects of the dividend and share buyback decisions, including(1) signaling effects, (2) clientele effects, and (3) finance and investment implications of increasing dividend payout and share repurchase decisions.
When discussing the cost of equity capital, or the rate of return required by investors for their share expenses, there are three main models widely used for analyzation. These models are the dividend growth model, which operates on the variable of growth and future trends, the capital asset pricing model (CAPM), which operates on the premise that higher returns are a result of higher risk, and the arbitrage pricing theory (APT), which has a more flexible set of criteria than CAPM and takes advantage of mispriced securities
Dividends are the distribution of profits in the company. It depends on the type of dividend policy made by companies. Dividend policy will affect the behaviours and attitudes of investors towards the company. Many economists or financial experts have constructed different theories to interpret the effects of a dividend policy to the society. But these theories are contestable since they are not tested in the real world. Managers’ decision on determining the size and time of a company’s next dividend payment is also important for both companies and shareholders. They will affect the company to distribute an appropriate amount of dividends in a right time. This essay will discuss whether theories of dividend payment, such as the dividend irrelevance and signalling effects are applicable in the real world. It will then describe some key factors that managers should consider on deciding the time and size of a company’s next dividend payment. Finally, it will conclude with the significance of a company’s decision on dividend payments.
Janssen is a division of Johnson and Johnsons that primarily focus on diseases that can help develop new strategies in improving prevention as well as developing vaccines and its accessibility to the world. The pharmaceutical company of J&J invests large amounts of money in research and development of its products. The competitive environment of Johnson and Johnson is very high for pharmaceutical companies due to which that many companies are releasing drug products and other devices. However, this company does not face any potential competitors due to which that it is a large company that provides a wide range of opportunities such as finances, and experiences. This leads to advantages compared to other competitors due to whom the pharmaceutical companies creates a barrier because of the high cost in research and development in medicine. In addition, Johnson and Johnson have to make sure that it has many suppliers for different categories for their products especially in medicine if one supplier causes shortages. Although suppliers do not bargain for the price values of its products, it still influences the price in the market in different countries. In addition, finding
DCF model could be the basic valuation, other valuing method, like Market Multiples should be considered to make result more accurate.
The reason I select Masteel’ stock to analyse is because I have looked back the historical stock chart of Masteel from 2009 to 2015, it is a declining price movement. Masteel achived the highest RM1.5 price in 2011 but it reduced to RM0.4 price in 2015. This historical price of stock in Masteel made me curios on its current intrinsic value and are this stock is worth to invest now? Thus, I would like to analyse Masteel’s stock value through stock valuation in part B, to figure out whether Masteel is worth to invest now and expect the price will increase in future.
Johnson and Johnson has been trading above both its 50 and 200 day averages and is promising. Its current market position is very attractive as it may become a market leader when the DOW turns around. Johnson and Johnson’s undervalued price, market position, and earnings make it a good pick in a sea of ambiguity.
With this information you can also see the following is a chart of the last two years of the stock for the same company: